Background The heterogeneity of genetic effects on major depressive disorder (MDD) may
be partly attributable to moderation of genetic effects by environment, such as exposure to …

Background Major depressive disorder is a clinically heterogeneous psychiatric disorder with
a polygenic architecture. Genome-wide association studies have identified a number of risk…

In polygenic score (PGS) analysis, the coefficient of determination (R 2 ) is a key statistic to
evaluate efficacy. R 2 is the proportion of phenotypic variance explained by the PGS, …

Background Foetal development indicates the risk of later disease, but has only been associated
with few psychiatric disorders. An aggregated molecular marker of development - DNA …

Background Gestational age is often used as a proxy for developmental maturity by clinicians
and researchers alike. DNA methylation has previously been shown to be associated with …

Background Although the pathogenic nature of copy number variants (CNVs) on chromosome
22q11.2 has been recognised for decades, unbiased estimates of their population …

Despite evidence for a genetic predisposition for intracranial aneurysm (IA), specific genes
that contribute to IA have yet to be identified. To assist in the identification of positional and …

Background Vascular malformations in the central nervous system are difficult to monitor and
treat due to their inaccessible location. Angiogenic and inflammatory proteins are secreted …

Among individuals with hereditary haemorrhagic telangiectasia (HHT), an estimated 40–50%
have pulmonary arteriovenous malformations (PAVMs) (anomalous direct communications …

Background Approximately 10% of people with hereditary hemorrhagic telangiectasia (HHT)
have brain vascular malformations (VMs). Few reports describe de novo brain VM formation…